$13.49
0.806.30%
In chiusura: -
$14.00
0.513.78%
After hour: 5:31 PM EDT
Comments
Loading...
Amylyx Pharmaceuticals Rapporto sugli interessi allo scoperto
AMLXNASDAQ
Report sulle vendite allo scoperto
Il short interest su Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 8.41M a 8.77M. Questo rappresenta il 8.92% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Amylyx Pharmaceuticals Corp (XNAS:AMLX) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 2.26M azioni scambiate al giorno, ci vorrebbero 3.88 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
8.77M
Vendite allo scoperto %
8.92%
Giorni di copertura
3.88
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
AMLX | Amylyx Pharmaceuticals, Inc. C | 09/15/2025 | 09/24/2025 | 8.92% | 98,352,405 | 8,774,952 | 2,262,263 | 3.88 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 08/29/2025 | 09/10/2025 | 10.41% | 80,769,058 | 8,410,918 | 1,545,878 | 5.44 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 08/15/2025 | 08/26/2025 | 9.20% | 80,769,058 | 7,433,417 | 890,116 | 8.35 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 07/31/2025 | 08/11/2025 | 8.91% | 80,769,058 | 7,192,631 | 1,215,070 | 5.92 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 07/15/2025 | 07/24/2025 | 9.24% | 80,769,058 | 7,466,420 | 1,932,538 | 3.86 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 06/30/2025 | 07/10/2025 | 8.20% | 80,769,058 | 6,622,803 | 2,604,055 | 2.54 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 06/13/2025 | 06/25/2025 | 5.00% | 80,769,058 | 4,039,910 | 849,501 | 4.76 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 05/30/2025 | 06/10/2025 | 5.12% | 80,769,058 | 4,131,846 | 1,030,996 | 4.01 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 05/15/2025 | 05/27/2025 | 6.16% | 80,769,058 | 4,972,837 | 1,121,643 | 4.43 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 04/30/2025 | 05/09/2025 | 5.20% | 80,769,058 | 4,198,819 | 825,406 | 5.09 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 04/15/2025 | 04/25/2025 | 5.34% | 80,769,058 | 4,312,023 | 862,179 | 5 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 03/31/2025 | 04/09/2025 | 4.58% | 82,396,376 | 3,775,634 | 627,516 | 6.02 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 03/14/2025 | 03/25/2025 | 4.55% | 82,396,376 | 3,747,333 | 1,043,819 | 3.59 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 02/28/2025 | 03/11/2025 | 4.43% | 82,396,376 | 3,652,423 | 554,487 | 6.59 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 02/14/2025 | 02/26/2025 | 4.25% | 79,484,625 | 3,378,306 | 755,647 | 4.47 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 01/31/2025 | 02/11/2025 | 3.26% | 79,484,625 | 2,591,408 | 1,048,173 | 2.47 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 01/15/2025 | 01/27/2025 | 3.12% | 79,484,625 | 2,482,384 | 808,403 | 3.07 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 12/31/2024 | 01/10/2025 | 3.12% | 62,341,768 | 1,942,447 | 731,100 | 2.66 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 12/13/2024 | 12/24/2024 | 2.51% | 62,341,768 | 1,565,509 | 722,151 | 2.17 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 11/29/2024 | 12/10/2024 | 2.32% | 62,341,768 | 1,448,789 | 1,241,670 | 1.17 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 11/15/2024 | 11/26/2024 | 2.45% | 62,341,768 | 1,526,219 | 1,623,747 | 1 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 10/31/2024 | 11/11/2024 | 2.07% | 62,341,768 | 1,289,340 | 2,074,048 | 1 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 10/15/2024 | 10/24/2024 | 1.63% | 61,876,376 | 1,010,282 | 994,088 | 1.02 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 09/30/2024 | 10/09/2024 | 2.07% | 61,876,376 | 1,279,759 | 1,588,647 | 1 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 09/13/2024 | 09/24/2024 | 2.03% | 61,876,376 | 1,258,866 | 1,020,791 | 1.23 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 08/30/2024 | 09/11/2024 | 2.40% | 61,876,376 | 1,487,177 | 655,290 | 2.27 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 08/15/2024 | 08/26/2024 | 3.19% | 61,876,376 | 1,971,065 | 1,223,550 | 1.61 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 07/31/2024 | 08/09/2024 | 3.00% | 61,876,376 | 1,856,225 | 1,067,540 | 1.74 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 07/15/2024 | 07/24/2024 | 6.11% | 61,799,657 | 3,778,482 | 2,889,774 | 1.31 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 06/28/2024 | 07/10/2024 | 7.39% | 61,799,657 | 4,569,062 | 3,002,185 | 1.52 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 06/14/2024 | 06/26/2024 | 11.67% | 61,799,657 | 7,212,555 | 1,058,976 | 6.81 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 05/31/2024 | 06/11/2024 | 12.25% | 61,799,657 | 7,569,728 | 1,152,541 | 6.57 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 05/15/2024 | 05/24/2024 | 12.93% | 61,799,657 | 7,989,883 | 1,612,178 | 4.96 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 04/30/2024 | 05/09/2024 | 13.78% | 61,799,657 | 8,514,537 | 2,132,371 | 3.99 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 04/15/2024 | 04/24/2024 | 10.54% | 61,799,657 | 6,512,835 | 2,613,255 | 2.49 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 03/28/2024 | 04/09/2024 | 11.80% | 50,891,344 | 6,007,147 | 2,509,117 | 2.39 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 03/15/2024 | 03/26/2024 | 10.01% | 50,891,344 | 5,091,917 | 9,586,073 | 1 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 02/29/2024 | 03/11/2024 | 8.58% | 50,891,344 | 4,367,278 | 2,024,431 | 2.16 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 02/15/2024 | 02/27/2024 | 9.78% | 50,891,344 | 4,979,419 | 826,795 | 6.02 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 01/31/2024 | 02/09/2024 | 10.74% | 50,626,958 | 5,439,346 | 866,381 | 6.28 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 01/12/2024 | 01/24/2024 | 11.32% | 50,626,958 | 5,728,735 | 1,348,296 | 4.25 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 12/29/2023 | 01/10/2024 | 10.75% | 50,626,958 | 5,443,430 | 1,066,376 | 5.1 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 12/15/2023 | 12/27/2023 | 13.16% | 50,626,958 | 6,660,026 | 1,300,496 | 5.12 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 11/30/2023 | 12/11/2023 | 13.72% | 50,626,958 | 6,943,949 | 1,180,290 | 5.88 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 11/15/2023 | 11/27/2023 | 13.96% | 50,626,958 | 7,068,023 | 2,773,230 | 2.55 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 10/31/2023 | 11/09/2023 | 15.67% | 50,626,958 | 7,932,638 | 1,348,266 | 5.88 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 10/13/2023 | 10/24/2023 | 19.34% | 50,486,948 | 9,765,149 | 1,658,142 | 5.89 | |
AMLX | Amylyx Pharmaceuticals, Inc. C | 09/29/2023 | 10/10/2023 | 17.35% | 50,486,948 | 8,757,715 | 1,197,732 | 7.31 |
In cerca di azioni più vendute allo scoperto?